Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: A multicenter analysis

Francesca D'Addio, Alessandro Valderrama Vasquez, Moufida Ben Nasr, Edward Franek, Dalong Zhu, Lirong Li, Guang Ning, Emilian Snarski, Paolo Fiorina

Research output: Contribution to journalArticle

Abstract

Type 1 diabetes (T1D) is one of the major autoimmune diseases affecting children and young adults worldwide. To date, the different immunotherapies tested have achieved insulin independence in

Original languageEnglish
Pages (from-to)3041-3046
Number of pages6
JournalDiabetes
Volume63
Issue number9
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: A multicenter analysis'. Together they form a unique fingerprint.

  • Cite this

    D'Addio, F., Vasquez, A. V., Nasr, M. B., Franek, E., Zhu, D., Li, L., Ning, G., Snarski, E., & Fiorina, P. (2014). Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: A multicenter analysis. Diabetes, 63(9), 3041-3046. https://doi.org/10.2337/db14-0295